Rapamycin News and Research

RSS
Rapamycin is a drug used to prevent the rejection of organ and bone marrow transplants by the body. Rapamycin is an antibiotic that blocks a protein involved in cell division and inhibits the growth and function of certain T cells of the immune system involved in the body's rejection of foreign tissues and organs. It is a type of immunosuppressant and a type of serine/threonine kinase inhibitor. Rapamycin is now called sirolimus.
Researchers identify molecular pathway underpinning exercise and improved motor learning

Researchers identify molecular pathway underpinning exercise and improved motor learning

Free fatty acids in the blood linked with elevated risk of breast cancer in obese women

Free fatty acids in the blood linked with elevated risk of breast cancer in obese women

Patients experiment with prescription drugs to fight aging

Patients experiment with prescription drugs to fight aging

Johns Hopkins scientists find new compound that may prevent reperfusion injury

Johns Hopkins scientists find new compound that may prevent reperfusion injury

Mutations in folliculin gene affect embryo implantation

Mutations in folliculin gene affect embryo implantation

Researchers identify new therapeutic targets for kidney fibrosis

Researchers identify new therapeutic targets for kidney fibrosis

Findings may open up new ways to treat dwarfism and other ER-stress-related conditions

Findings may open up new ways to treat dwarfism and other ER-stress-related conditions

Drug cocktail that increases lifespan discovered

Drug cocktail that increases lifespan discovered

Studies demonstrate effect of Ketogenic Diet on cognitive health in animals

Studies demonstrate effect of Ketogenic Diet on cognitive health in animals

Researchers design modeling system to infer relationships between genes, drugs, and their environment

Researchers design modeling system to infer relationships between genes, drugs, and their environment

Drug treatment at a young age could help reverse autism-like behavior in tuberous sclerosis

Drug treatment at a young age could help reverse autism-like behavior in tuberous sclerosis

New federally-funded research project could lead to treatments that extend human lifespan

New federally-funded research project could lead to treatments that extend human lifespan

Study: Matcha green tea kills breast cancer stem cells

Study: Matcha green tea kills breast cancer stem cells

Study suggests new strategies for using cell metabolism to treat cancer

Study suggests new strategies for using cell metabolism to treat cancer

Pediatric researchers discover gene mutation that causes lymphatic disorder

Pediatric researchers discover gene mutation that causes lymphatic disorder

MSU researchers uncover the effects of aging on regenerative ability of kidneys

MSU researchers uncover the effects of aging on regenerative ability of kidneys

Novel informatics tool helps predict genomic features associated with specific drug responses

Novel informatics tool helps predict genomic features associated with specific drug responses

Researchers identify molecular mechanism leading to cortical malformation from brain-only mutations

Researchers identify molecular mechanism leading to cortical malformation from brain-only mutations

Scientists focus on critical regulatory protein to find clues on cancer, neurodegenerative diseases

Scientists focus on critical regulatory protein to find clues on cancer, neurodegenerative diseases

Scientists point to potentially promising treatment target for deadly brain cancers

Scientists point to potentially promising treatment target for deadly brain cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.